Literature DB >> 2990492

Antiproliferative properties of phorbol ester tumour promoters.

A Gescher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990492     DOI: 10.1016/0006-2952(85)90552-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Continuous synthesis of two protein-kinase-C-related proteins after down-regulation by phorbol esters.

Authors:  C Borner; U Eppenberger; R Wyss; D Fabbro
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

2.  Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression.

Authors:  P M Choi; K M Tchou-Wong; I B Weinstein
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

3.  Yeast phenotype classifies mammalian protein kinase C cDNA mutants.

Authors:  H Riedel; L Su; H Hansen
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

4.  Down-regulation of protein kinase C is due to an increased rate of degradation.

Authors:  S Young; P J Parker; A Ullrich; S Stabel
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

Review 5.  Biology of the protein kinase C family.

Authors:  C A O'Brian; N E Ward
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

Review 6.  Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents.

Authors:  A Gescher
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

Review 7.  Review of survival analyses published in cancer journals.

Authors:  D G Altman; B L De Stavola; S B Love; K A Stepniewska
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

8.  A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

Authors:  G C Jayson; D Crowther; J Prendiville; A T McGown; C Scheid; P Stern; R Young; P Brenchley; J Chang; S Owens
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.